Healthcare -
Biotechnology - NASDAQ - US
$ 36.91
0.819 %
$ 3.49 B
Market Cap
-6.33
P/E
RARE - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss RARE - Ultragenyx Pharmaceutical Inc.
-643 K
LAST VALUE
68.72%
2 YEAR CAGR
-34.33%
5 YEAR CAGR
-13.96%
10 YEAR CAGR